Mobia Medical (NASDAQ:MOBI) Releases Quarterly Earnings Results

Mobia Medical (NASDAQ:MOBI) released its earnings results on Thursday. The company reported $999.00 EPS for the quarter, Zacks reports.

Mobia Medical Stock Performance

Shares of NASDAQ MOBI traded up $0.11 during mid-day trading on Thursday, hitting $13.84. The company had a trading volume of 240,618 shares, compared to its average volume of 173,512. The stock has a market cap of $457.90 million, a PE ratio of 66.00 and a beta of 2.84. Mobia Medical has a 1 year low of $10.19 and a 1 year high of $14.77.

Insider Buying and Selling at Mobia Medical

In other news, major shareholder Osage University Gp Iii, Llc purchased 533,333 shares of the company’s stock in a transaction on Monday, May 11th. The stock was purchased at an average price of $15.00 per share, with a total value of $7,999,995.00. Following the completion of the purchase, the insider directly owned 2,006,716 shares in the company, valued at approximately $30,100,740. This trade represents a 36.20% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Cynthia L. Lucchese bought 125,000 shares of Mobia Medical stock in a transaction dated Monday, May 11th. The shares were acquired at an average cost of $15.00 per share, for a total transaction of $1,875,000.00. Following the completion of the purchase, the director directly owned 125,000 shares of the company’s stock, valued at approximately $1,875,000. This trade represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought 1,268,332 shares of company stock valued at $19,024,980 over the last 90 days.

Analyst Ratings Changes

A number of brokerages have commented on MOBI. BTIG Research began coverage on Mobia Medical in a report on Tuesday. They issued a “buy” rating and a $19.00 price objective on the stock. Bank of America started coverage on Mobia Medical in a research note on Tuesday. They issued a “buy” rating and a $16.00 price target for the company. The Goldman Sachs Group started coverage on Mobia Medical in a research note on Tuesday. They issued a “buy” rating and a $31.00 price target for the company. Wall Street Zen raised Mobia Medical to a “hold” rating in a research note on Saturday, May 16th. Finally, JPMorgan Chase & Co. began coverage on Mobia Medical in a research note on Tuesday. They issued an “overweight” rating and a $15.00 price target for the company. Five research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Mobia Medical currently has an average rating of “Buy” and an average target price of $20.25.